Skip to main content

Table 4 Cox proportional regression analysis for predictors of disease-free survival

From: Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy and intraoperative radiation therapy in the management of gastric cancer: a 10-year single center experience

Parameter

Univariate analysis

Multivariate analysis

HR (95% CI)

P-value

HR (95% CI)

P-value

Gender

 

0.957

  

Female

Ref

Male

0.98(0.47–2.01)

Age at diagnosis

 

0.841

  

 ≤ 57 years

Ref

 > 57 years

0.93(0.43–1.84)

BMI

    

< 18.5

Ref

 

18.5–29.9

0.66(0.19–2.19)

0.499

≥ 30

0.37(0.08–1.70)

0.204

Comorbidities

 

0.394

  

No

Ref

Yes

1.35(0.67–2.70)

Adjuvant (Post-operative chemotherapy)

 

0.783

  

No

Ref

Yes

0.90(0.45–1.79)

PCI

 

< 0.001

  

≤ 6

Ref

Ref

 

> 6

4.44(2.17–9.11)

3.4(1.44- 8.00)

0.005

CC

 

0.01

  

0

Ref

1

4.27(1.40–12.9)

Postoperative complications

    

No

Ref

 

Yes

2.18(0.98–4.86)

0.056

Length of hospital stay

 

0.207

  

 ≤ 21 days

Ref

 > 21 days

1.55(0.78–3.11)

Tumor type

    

Intestinal

Ref

 

Adenocarcinoma

2.97(0.81–10.77)

0.097

Diffuse

1.88(0.85–4.12)

0.114

mixed

0.97(0.27–3.54)

0.975

Tumor location

    

GEJ junction

Ref

 

Ref

 

antrum

0.35(0.12–0.96)

0.043

0.28(0.14–0.88)

0.03

 body

0.30(0.03–2.36)

0.255

  

cardia

0.39(0.08–1.83)

0.234

  

overlapping location

1.90(0.68–5.28)

0.213

  

fundus

1.02(0.22–4.67)

0.979

  

pylorus

0.63(0.21–1.87)

0.416

  

Surgery type

    

-Radical total gastrectomy with D2 lymphadenectomy

Ref

 

Ref

 

- Subtotal esophagectomy and total gastrectomy with D2 lymphadenectomy and colon interposition

    
 

3.43(1.52–7.75)

0.003

2.94(1.05–8.28)

0.04

Signet sign

    

Absent

Ref

 

Present

1.25(0.63–2.50)

0.512

Staging

    

Stage 1a/b- 3a/b/c

Ref

 

Stage 4

3.13(1.52 6.42)

0.002

Resection Margin

    

Negative

Ref

 

Positive

2.15(0.92- 5.00)

0.074

Lymphovascular invasion

    

Absent

Ref

 

Present

2.37(1.19–4.73)

0.014

Perineural invasion

    

Absent

Ref

 

Ref

 

Present

2.55(1.26–5.16)

0.009

3.02(1.28–7.11)

0.012

Her 2 neu expression

    

Negative

Ref

 

Positive

0.94(0.40–2.18)

0.895

Clavien-dindo ≥ III

    

No

Ref

 

Ref

 

Yes

2.98 (1.49–5.96)

0.002

2.66 (1.15–6.13)

0.021

  1. Note: *P-value significant at < 0.1; †P-value significant at < 0.05; HR = Hazard Ratio; CI = Confidence interval